FR2182942B1 - - Google Patents

Info

Publication number
FR2182942B1
FR2182942B1 FR7312663A FR7312663A FR2182942B1 FR 2182942 B1 FR2182942 B1 FR 2182942B1 FR 7312663 A FR7312663 A FR 7312663A FR 7312663 A FR7312663 A FR 7312663A FR 2182942 B1 FR2182942 B1 FR 2182942B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7312663A
Other languages
French (fr)
Other versions
FR2182942A1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rustenburg Platinum Mines Ltd
Original Assignee
Rustenburg Platinum Mines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rustenburg Platinum Mines Ltd filed Critical Rustenburg Platinum Mines Ltd
Publication of FR2182942A1 publication Critical patent/FR2182942A1/fr
Application granted granted Critical
Publication of FR2182942B1 publication Critical patent/FR2182942B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7312663A 1972-04-10 1973-04-09 Expired FR2182942B1 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1645172A GB1432563A (en) 1972-04-10 1972-04-10 Platinum- co-ordination compounds
GB2139072 1972-05-08

Publications (2)

Publication Number Publication Date
FR2182942A1 FR2182942A1 (enExample) 1973-12-14
FR2182942B1 true FR2182942B1 (enExample) 1976-10-22

Family

ID=26252050

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7312663A Expired FR2182942B1 (enExample) 1972-04-10 1973-04-09

Country Status (7)

Country Link
US (1) US3904663A (enExample)
JP (1) JPS535369B2 (enExample)
DE (1) DE2318021A1 (enExample)
FR (1) FR2182942B1 (enExample)
GB (1) GB1432563A (enExample)
NL (1) NL7304881A (enExample)
SE (1) SE396755B (enExample)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4419340A (en) * 1969-03-24 1983-12-06 University Of Delaware Controlled release of anticancer agents from biodegradable polymers
GB1578323A (en) * 1976-02-26 1980-11-05 Rustenburg Platinum Mines Ltd Compositions containing platinum
GB1585103A (en) * 1976-04-06 1981-02-25 Rustenburg Platinum Mines Ltd Pharmaceutical compositions containing platinum compounds
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
US4115418A (en) * 1976-09-02 1978-09-19 Government Of The United States Of America 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
US4151185A (en) * 1977-05-02 1979-04-24 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4278660A (en) * 1977-05-02 1981-07-14 Research Corporation Complex or salt of a platinum (II) compound and a nitrogen containing polymer
US4137248A (en) * 1977-08-29 1979-01-30 The United States Of America As Represented By The Department Of Health, Education And Welfare Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof
JPS5829957B2 (ja) * 1977-09-12 1983-06-25 喜徳 喜谷 新規な白金錯体
US4230631A (en) * 1977-10-19 1980-10-28 Johnson, Matthey & Co., Limited Platinum coordination compounds
NL7810433A (nl) * 1977-10-19 1979-04-23 Johnson Matthey Co Ltd Nieuwe platinaverbindingen.
SE447902B (sv) * 1977-10-19 1986-12-22 Johnson Matthey Co Ltd Cis-koordinationsforening av platina och komposition innehallande foreningen
NL7807334A (nl) * 1978-07-06 1980-01-08 Tno Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
US4405757A (en) * 1979-09-14 1983-09-20 Howell Bobby A Macromolecular complexes of amidocarbonylic water-soluble polymers and square planar platinous and equivalent organometallics
US4578491A (en) * 1982-06-28 1986-03-25 Engelhard Corporation Bis(thiocyanato)palladium(II) complexes
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
US4560782A (en) * 1982-11-19 1985-12-24 Research Corporation Anti-tumor diplatinum coordination compounds
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
AU558747B2 (en) * 1983-05-10 1987-02-05 Andrulis Research Corporation Bis-platinum complexes as antitumor agents
US4544759A (en) * 1983-07-29 1985-10-01 American Cyanamid Company Platinum complexes of antitumor agents
US4588831A (en) * 1984-11-09 1986-05-13 Natec Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
US5117022A (en) * 1985-10-18 1992-05-26 The Board Of Regents, The University Of Texas System Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5041581A (en) * 1985-10-18 1991-08-20 The University Of Texas System Board Of Regents Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
US5384127A (en) * 1985-10-18 1995-01-24 Board Of Regents, The University Of Texas System Stable liposomal formulations of lipophilic platinum compounds
US5041578A (en) * 1988-11-22 1991-08-20 Board Of Regents, The University Of Texas System Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
US5393909A (en) * 1988-11-22 1995-02-28 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5434256A (en) * 1988-11-22 1995-07-18 Board Of Regents, The University Of Texas System Diamine platinum complexes as antitumor agents
US5843475A (en) * 1996-12-06 1998-12-01 Board Of Regents, The University Of Texas System Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes
BR0013971A (pt) * 1999-09-14 2003-07-15 Smithkline Beecham Corp Sistema de fechamento de contêiner
AU1608801A (en) 1999-11-15 2001-05-30 Parker Hughes Institute Diamino platinum (ii) antitumor complexes
JP2007502301A (ja) * 2003-08-13 2007-02-08 ユニバーシティー オブ サウス フロリダ 腫瘍細胞の増殖を阻害するための方法
US20050288365A1 (en) * 2004-01-06 2005-12-29 Heidi Kay Platinum complexes and methods for inhibiting tumor cell proliferation
US7977500B2 (en) * 2004-11-10 2011-07-12 University Of South Florida Platinum complexes for targeted drug delivery
WO2007006019A1 (en) * 2005-07-06 2007-01-11 University Of South Florida Materials and methods for screening, diagnosis and prognosis of conditions associated with stat protein expression
CN103705947A (zh) 2006-06-28 2014-04-09 株式会社Ihi 药物、药物引导装置、磁性检测装置和药物设计方法
JP4774536B2 (ja) * 2006-11-06 2011-09-14 株式会社Ihi 磁性材料、磁性材料の誘導装置及び磁性材料の設計方法
US20090169484A1 (en) 2007-12-28 2009-07-02 Ihi Corporation Iron-salen complex
EP2357166B1 (en) 2008-11-20 2020-01-15 IHI Corporation Auto magnetic metal salen complex compound
ES2862331T3 (es) 2010-06-18 2021-10-07 Myriad Genetics Inc Métodos para predecir el estado de los genes BRCA1 y BRCA2 en una célula de cáncer
DK3109325T3 (en) 2010-08-24 2019-01-28 Dana Farber Cancer Inst Inc Methods for predicting anticancer response
EP4563709A3 (en) 2011-06-17 2025-09-03 Myriad Genetics, Inc. Methods and materials for assessing allelic imbalance
EP4497824A3 (en) 2011-12-21 2025-04-16 Myriad Genetics, Inc. Methods and materials for assessing loss of heterozygosity
CA3080441C (en) 2012-02-23 2026-01-06 The Technical University Of Denmark Methods for predicting anti-cancer response
CA3126823C (en) 2012-06-07 2023-04-04 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
US10308986B2 (en) 2013-03-14 2019-06-04 Children's Medical Center Corporation Cancer diagnosis, treatment selection and treatment
CA2908745C (en) 2013-04-05 2023-03-14 Myriad Genetics, Inc. Methods and materials for assessing homologous recombination deficiency
CA2931181C (en) 2013-12-09 2023-01-24 Institut Curie Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
DK4234711T3 (da) 2014-08-15 2025-08-25 Myriad Genetics Inc Fremgangsmåder og materialer til vurdering af mangel på homolog rekombination
EP4141127B1 (en) 2021-08-30 2024-10-09 Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln Method for assessing homologous recombination deficiency in ovarian cancer cells

Also Published As

Publication number Publication date
US3904663A (en) 1975-09-09
FR2182942A1 (enExample) 1973-12-14
JPS4913317A (enExample) 1974-02-05
NL7304881A (enExample) 1973-10-12
GB1432563A (en) 1976-04-22
SE396755B (sv) 1977-10-03
JPS535369B2 (enExample) 1978-02-27
DE2318021A1 (de) 1973-11-08

Similar Documents

Publication Publication Date Title
FR2182942B1 (enExample)
FR2212739A1 (enExample)
JPS4943577U (enExample)
JPS491258U (enExample)
FR2208424A5 (enExample)
JPS5213137B2 (enExample)
JPS4956817A (enExample)
DK141704C (enExample)
JPS5534434B2 (enExample)
JPS5352331Y2 (enExample)
AU465382B2 (enExample)
CS150338B1 (enExample)
JPS4884047U (enExample)
JPS4883368A (enExample)
JPS4950812U (enExample)
AU4040772A (enExample)
CS152708B1 (enExample)
CS152245B1 (enExample)
CS152243B1 (enExample)
CS150474B1 (enExample)
CS150342B1 (enExample)
CH595104A5 (enExample)
BG18206A1 (enExample)
CH605668A5 (enExample)
CH601027A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse